Press Releases
 
Injectable Targeted Therapy Market Share and Growth Factors Impact Analysis 2014 - 2020

, 17 April 2019 -- Injectable Targeted Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

Targeted delivery is a clinical treatment used to deliver medication in patients to increase the concentration of medication in some parts of the body. Target specific drug delivery is localized, prolonged, targeted and have protected drug interaction with the diseased tissue. The advantage of injectable targeted therapy was the decrease in frequency of the dosages that are delivered to the patient, it more uniform effect of the drug, reduction of drug’s side-effects and reduced oscillation in circulating drug levels.

Obtain Report Details @ https://www.transparencymarketresearch.com/injectable-targeted-therapy.html

The most important characteristics of targeted drug delivery system are non-toxic, non-immunogenic, both physically and chemically stable in-vivo and in-vitro and controllable and predictable rate of drug release. The various types of delivery vehicles used in injectable targeted therapy are liposomes, micelles, dendrimers, biodegradable particles and artificial DNA nanostructures.

The applications of injectable targeted therapy are widely classified such as cardiovascular diseases, respiratory diseases and diabetes, but the primary application of injectable targeted therapy is in oncology. The injectable drugs primary target range included oncology, hormonal imbalances, autoimmune diseases, orphan/rare diseases (Cystic Fibrosis, Ribose-5-phosphate isomerase deficiency or RPI deficiency, Hemophilia and Wilson\’s disease) and others (allergies, aesthetic treatment hepatitis C and pain management).

Request Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2772

The major drivers of injectable targeted therapy market are growing prevalence of senile disorders, sedentary lifestyle and increasing prevalence of cancer. According to World Health Organization (WHO), there were 14.1 million new cancer cases, 8.2 million cancer deaths and 32.6 million people living with cancer (within 5 years of diagnosis) in 2012 worldwide. While in same year 57% (8 million) of new cancer cases, 65% (5.3 million) of the cancer deaths and 48% (15.6 million) of the 5-year prevalent cancer cases occurred in the less developed regions from African and Asian continent. The prevalence of cancer is expected to increase and predicted to reach 24 million by 2035.

North America was observed to be the largest market for injectable targeted therapy as it’s a technologically advanced and premium therapy; the highest clinical research studies on targeted therapy market are going in the U.S. and Canada. Followed by Europe, the novel injectable target therapy is applied in most of the oncology cases in United Kingdom, Germany, France, Italy and Spain.

Asia-Pacific and Rest of the World (RoW) consists of most of the emerging markets in the world such as India, China, Brazil and Mexico. The injected targeted therapy market in these geographies is currently at initial stages while in Japan this dosage form was observed to be the therapy of choice in most of the oncology patient treatment. Overall demand for targeted drugs is expected to grow in these regions especially after expected breakthroughs in cardiovascular, respiratory and diabetes applications.

Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=2772

The global trend observed in injectable targeted therapy market was increased deals in targeted drug delivery companies and ventures are expected to drive the partnership research programs in this therapy market. Some of the major players in Injectable targeted therapy market are Becton Dickinson, SHL Group, Ypsomed Holding AG, Terumo Medical Corp., Schott AG, Owen Mumford Ltd and Antares Pharma Inc.

Some market players currently researching on this technology are Actavis plc, Astra Zeneca plc, GlaxoSmithKline, Merus Laboratories International Inc., National Cancer Institute, Novartis AG, Amgen, Bristol-Myers Squibb, Unilife Corporation, Ligand Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc. and others.

# # #


Submitted by hawer on Wednesday, 17 April 2019 at 10:01 PM
Category: Health Care & Medical
 
Related News

Coronary Stents Market: Increase in Geriatric Population to Drive Demand
Friday, 19 Apr 2019

Wearable Medical Devices Market - Rising Number of Sports and Fitness Enthusiasts to Boost the Deman
Friday, 19 Apr 2019

Catheters Market - Increasing Demand for Minimally Invasive Surgeries to Spur the Demand
Friday, 19 Apr 2019

Fragment-based Drug Discovery Market Will be Worth US$1.15 bn by 2023
Friday, 19 Apr 2019

Homeopathy Product Market is Projected to be Worth US$17,486.2 mn by 2024
Friday, 19 Apr 2019

Related Events

3rd Annual NASH Summit | April 22-25, 2019 | Boston, MA
Monday, 22 Apr 2019

Rx Drug Abuse and Heroin Summit
Monday, 22 Apr 2019

European NeoAg Summit 2019
Tuesday, 23 Apr 2019

MASS East
Wednesday, 24 Apr 2019

8th Digital Marketing for Medical Devices West
Wednesday, 24 Apr 2019

Latest News

Paramarketing.gr SEO Agency to Boost Your Website Traffic with Latest Technology and Smart SEO Techn
Sunday, 21 Apr 2019

Four Years of Despair Book Launch
Sunday, 21 Apr 2019

ΑΠΟΦΡΑΞΕΙΣ ΑΘΗΝΑ Α&#
Sunday, 21 Apr 2019

Infographic presenting the 6 Steps to Sell a House in Wisconsin
Sunday, 21 Apr 2019

Benefits of the Amazing Red Tea for Weight Loss in the Healthiest Way
Sunday, 21 Apr 2019

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2019
Today is Sunday, 21 April 2019

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • Palo Alto Networks: Palo Alto Networks Next Generation Firewall Hands-on Seminar
  • DOZ Live Inspirational Conference (DOZ Live)
  • 3rd Annual NASH Summit | April 22-25, 2019 | Boston, MA
  • Rx Drug Abuse and Heroin Summit
  • European NeoAg Summit 2019

  • Latest Jobs
    Sorry, there are currently no entries posted here.